Prognostic impact of additional extended surgical procedures in advanced-stage primary ovarian cancer

Annals of Surgical Oncology

Volumn 17, Issue 1, 2010, Pages 279-286

  Kommoss, S ^a   Rochon, J ^b   Harter, P ^a   Heitz, F ^a   Grabowski, J P ^a   Ewald Riegler, N ^a   Haberstroh, M ^a   Neunhoeffer, T ^a   Barinoff, J ^a   Gomez, R ^a   Traut, A ^a   Du Bois, A ^a  

^a DR HORST SCHMIDT KLINIKEN   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

ABDOMINAL HYSTERECTOMY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE SEVERITY; FEMALE; HUMAN; LUNG EMBOLISM; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MORBIDITY; OVARY CANCER; OVARY CARCINOMA; OVERALL SURVIVAL; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; POSTOPERATIVE COMPLICATION; PROGNOSIS; REOPERATION; RISK FACTOR; SALPINGOOOPHORECTOMY; SURGICAL RISK; SURVIVAL RATE; TERTIARY HEALTH CARE;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 74649083465     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0787-8     Document Type: Article

References (29)

1. du Bois A, Quinn M, Thigpen T, et al. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol. 2005;16(Suppl 8):viii7-viii12.
2. RE Bristow RS Tomacruz DK Armstrong EL Trimble FJ Montz 2002 Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 20 1248 1259 10.1200/JCO.20.5. 1248 11870167 (Pubitemid 34177431)
3. A du Bois A Reuss E Pujade-Lauraine P Harter I Ray-Coquard J Pfisterer 2009 Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO) Cancer. 115 1234 1244 10.1002/cncr.24149 1:CAS:528:DC%2BD1MXktlKnsL4%3D 19189349
4. FJ Montz JB Schlaerth JS Berek 1989 Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer Gynecol Oncol 35 338 340 10.1016/0090-8258(89)90074-7 1:STN:280:DyaK3c%2FptlWhuw%3D%3D 2599468 (Pubitemid 20025897)
5. LM Chen RS Leuchter LD Lagasse BY Karlan 2000 Splenectomy and surgical cytoreduction for ovarian cancer Gynecol Oncol 77 362 368 10.1006/gyno.2000.5800 1:STN:280:DC%2BD3c3ptlSrsg%3D%3D 10831343 (Pubitemid 30368551)
6. MA Merideth WA Cliby GL Keeney TG Lesnick DM Nagorney KC Podratz 2003 Hepatic resection for metachronous metastases from ovarian carcinoma Gynecol Oncol 89 16 21 10.1016/S0090-8258(03)00004-0 12694649 (Pubitemid 36403643)
7. EL Eisenhauer NR Abu-Rustum Y Sonoda, et al. 2006 The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer Gynecol Oncol 103 1083 1090 10.1016/j.ygyno.2006.06.028 16890277 (Pubitemid 44821338)
8. WH Kruskal WAL Wallis 1952 Use of ranks in one-criterion variance analysis J Am Stat Assoc 47 583 621 10.2307/2280779
9. Armitage PBG. Statistical methods in medical research, 3rd ed. Oxford: Blackwell; 1994.
10. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481 10.2307/2281868
11. N Mantel 1966 Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep. 50 163 170 1:STN:280:DyaF287ht1Wgug%3D%3D 5910392
12. DR Cox 1972 Regression models and life tables J R Stat Soc B 34 187 202
13. Meigs J. Tumors of the female pelvic organs. New York: Macmillan; 1934.
14. WJ Hoskins WP McGuire MF Brady HD Homesley WT Creasman M Berman H Ball JS Berek 1994 The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma Am J Obstet Gynecol 170 974 979 1:STN:280:DyaK2c3hvFGntQ%3D%3D 8166218 discussion 979-80
15. SM Eisenkop RL Friedman HJ Wang 1998 Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study Gynecol Oncol 69 103 108 10.1006/gyno.1998.4955 1:STN:280:DyaK1c3mtlajuw%3D%3D 9600815 (Pubitemid 28246994)
16. RE Bristow FJ Montz LD Lagasse RS Leuchter BY Karlan 1999 Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer Gynecol Oncol 72 278 287 10.1006/gyno.1998.5145 1:STN:280:DyaK1M7msVWhuw%3D%3D 10053096 (Pubitemid 29118182)
17. CT Griffiths 1975 Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma Natl Cancer Inst Monogr. 42 101 104 1:STN:280:DyaE2s%2Fls1ejsQ%3D%3D 1234624
18. MS Piver T Baker 1986 The potential for optimal (less than or equal to 2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: a prospective study Gynecol Oncol 24 1 8 10.1016/0090-8258(86)90001-6 1:STN:280:DyaL287ptlOlsg%3D%3D 3699571 (Pubitemid 16104350)
19. GD Aletti SC Dowdy BS Gostout, et al. 2006 Aggressive surgical effort and improved survival in advanced-stage ovarian cancer Obstet Gynecol 107 77 85 16394043
20. DS Chi EL Eisenhauer J Lang, et al. 2006 What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103 559 564 10.1016/j.ygyno.2006.03.051 1:STN:280:DC%2BD28nktFCmug%3D%3D 16714056 (Pubitemid 44602167)
21. EL Eisenhauer NR Abu-Rustum Y Sonoda C Aghajanian RR Barakat DS Chi 2008 The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer Gynecol Oncol 108 276 281 10.1016/j.ygyno.2007.10.022 1:CAS:528: DC%2BD1cXhtlOqsbs%3D 18063020
22. SM Eisenkop NM Spirtos 2001 Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival? Gynecol Oncol 82 435 441 10.1006/gyno.2001. 6313 1:STN:280:DC%2BD3Mvnslahsg%3D%3D 11520137 (Pubitemid 32826441)
23. AL Covens 2000 A critique of surgical cytoreduction in advanced ovarian cancer Gynecol Oncol 78 269 274 10.1006/gyno.2000.5926 1:STN:280: DC%2BD3cvlsl2ltg%3D%3D 10985879 (Pubitemid 30688731)
24. M Markman 2007 Concept of optimal surgical cytoreduction in advanced ovarian cancer: a brief critique and a call for action J Clin Oncol 25 4168 4170 10.1200/JCO.2007.11.8992 17724348 (Pubitemid 47548554)
25. NF Hacker 1989 Controversial aspects of cytoreductive surgery in epithelial ovarian cancer Baillieres Clin Obstet Gynaecol. 3 49 57 10.1016/S0950-3552(89)80041-0 1:STN:280:DyaL1M3ovVyntA%3D%3D 2472243
26. T Le GV Krepart RJ Lotocki MS Heywood 1997 Does debulking surgery improve survival in biologically aggressive ovarian carcinoma? Gynecol Oncol 67 208 214 10.1006/gyno.1997.4839 1:STN:280:DyaK1c%2FjsFymuw%3D%3D 9367710 (Pubitemid 27500422)
27. R Naik A Nordin PA Cross D Hemming A de Barros Lopes JM Monaghan 2000 Complete cytoreduction: is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease? Gynecol Oncol 78 176 180 10.1006/gyno.2000.5842 1:STN:280:DC%2BD3cvht1emsw%3D%3D 10926799 (Pubitemid 30650350)
28. NM Spirtos GM Gross JL Freddo SC Ballon 1995 Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy Gynecol Oncol 56 345 352 10.1006/gyno.1995.1061 1:STN:280:DyaK2M3itVOjtQ%3D%3D 7705667
29. GD Aletti KC Podratz JP Moriarty WA Cliby KH Long 2009 Aggressive and complex surgery for advanced ovarian cancer: an economic analysis Gynecol Oncol 112 16 21 10.1016/j.ygyno.2008.10.008 19027146